Examinar
Envíos recientes
Ítem Solo Metadatos High impact of SARS-CoV-2 or COVID-19 in the Honduran health personnel(John Wiley and Sons Inc, 2021)Ítem Solo Metadatos Ítem Solo Metadatos Evidence regarding use of corticosteroids in deep cervicofacial infections of odontogenic origin(Churchill Livingstone, 2020)Ítem Solo Metadatos Enhanced antibiotic resistance as a collateral COVID-19 pandemic effect?(W.B. Saunders Ltd, 2021)Ítem Solo Metadatos Diabetes care during COVID 19: experience in telemedicine from a developing country(Elsevier Ltd, 2020)Ítem Solo Metadatos Ítem Solo Metadatos Ítem Solo Metadatos COVID-19 infection during the Olympic and Paralympic Games Tokyo 2020(Elsevier Inc., 2021)Ítem Solo Metadatos COVID-19 reinfection? A suspected case in a Peruvian patient(Elsevier Inc., 2021)Ítem Solo Metadatos Comfort and compliance with the use of facemasks during COVID -19 infection(Churchill Livingstone, 2020)Ítem Solo Metadatos Ítem Solo Metadatos Viruela del mono: a un paso de que la historia se repita [Monkeypox: one step away from history repeating itself](Elsevier Espana S.L.U, 2022)Ítem Solo Metadatos Ítem Solo Metadatos Ítem Solo Metadatos Association between hypertension and immunosuppression in Sars-Cov-2 infection(Modestum LTD, 2021)Coronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Further research in pathways that justify the association between hypertension and immunosuppression in COVID-19 patients is recommended. © 2021 by Author/s and Licensed by Modestum.Ítem Solo Metadatos Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?(John Wiley and Sons Inc, 2020)